Next, Western blotting and qPCR assays were conducted which revealed marked AIM2 upregulation in SGC-7901, BGC-823, MGC803, and MKN45 in GC cells relative to control GES-1 cells (P < 0.05, Figures 2(a) and 2(b)). This evidence concerns the gene AIM2 and gastric cancer.